Estrogen is the primary female sex hormone. Improving estrogen metabolism is of benefit to women who suffer from estrogen-dominant conditions such as endometriosis, premenstrual syndrome, and uterine fibroid tumors.

DNA Estrogen® tests for gene variants that have been shown to have an impact on how estrogen is metabolized and how estrogen is processed in the body. How efficiently estrogen and related compounds are processed is a key factor in risk of breast cancers.

Healthcare practitioners use the DNA Estrogen® test results to prescribe individualized nutritional and lifestyle interventions to mitigate breast cancer risk in women with high-risk genetic profiles. The personalization of diet, hormone, and nutritional supplement recommendations can assist to improve estrogen metabolism.

DNA Estrogen® reports on the following areas:

• Variations in key genes involved in metabolizing estrogen and related compounds
• Impact of high-risk gene variations
• Intervention strategies for carriers of high-risk genetic variations
• Personal risk factors associated with HRT, oral contraceptives, bio-identical supplementation, and in vitro fertilization ​

​​Who needs this gene panel?

• Women suffering from endometriosis, premenstrual syndrome (PMS), or uterine fibroid tumors
• Individuals with a family history of breast or prostate cancer
• Individuals considering hormone replacement therapy